JAVELIN Pharmaceuticals Common Stock Begins Trading Tomorrow on The Amex(R) Under The Symbol JAV.CAMBRIDGE, Mass. -- Javelin Pharmaceuticals, Inc. (AMEX AMEX See: American Stock Exchange :JAV JAV Javanese JAV Japanese Adult Video JAV Ilulissat, Greenland (Airport Code) JAV Jeanne d'Arc de Vaugirard (Paris) JAV Journey Adventure Vehicle JAV Java Applet Viewer JAV Java Alignment Viewer ), today announced that its's common stock will begin trading on the American Stock Exchange American Stock Exchange (AMEX) Stock exchange in the U.S. Originally known as “the Curb,” it began as an outdoor marketplace in New York City c. 1850. It moved indoors to its present location in the Wall Street area in 1921. tomorrow Thursday July 20, 2006 under the ticker symbol Ticker Symbol An arrangement of characters (usually letters) representing a particular security listed on an exchange or otherwise traded publicly. When a company issues securities to the public marketplace, it selects an available ticker symbol for its securities which investors JAV. About Javelin With corporate headquarters in Cambridge, MA, Javelin applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs to target unmet and underserved medical needs in the pain management market. The Company has two drug candidates in Phase III clinical development and one in late Phase II. One of these Phase III drug candidates, Dyloject(TM), is currently under review for Marketing Authorization Application (MAA MAA abbr. macroaggregated albumin ) approval in Europe. Previous clinical trials have demonstrated its safety and rapid onset of action onset of action Pharmacology The length of time needed for a medicine to become effective. See Therapeutic drug monitoring. . For additional information about Javelin, please visit the company's website at http://www.javelinpharmaceuticals.com or contact us directly. Forward Looking Statement This news release contains forward-looking statements. Such statements are valid only as of today, and we disclaim any obligation to update this information. These statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. These statements are based on our current beliefs and expectations as to such future outcomes. Drug discovery and development involve a high degree of risk. Factors that might cause such a material difference include, among others, uncertainties related to the ability to attract and retain partners for our technologies, the identification of lead compounds, the successful preclinical development thereof, the completion of clinical trials, the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. review process and other governmental regulation, our ability to obtain working capital, our ability to successfully develop and commercialize drug candidates, and competition from other pharmaceutical companies. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion